How serious is FDA warning about revolutionary blood-cancer

Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.

Car-T Therapy May Increase Risk of Certain Cancers

Your Cholesterol Test Might Not Be FDA Approved. The Agency Wants to Change That. - WSJ

Health Archives — Harvard Gazette

Archives — Page 5 of 875 — Harvard Gazette

FDA Approves Second Personalized Therapy for Cancer

Mark Flower on LinkedIn: As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR…

Oncology Health Central

Immunotherapy - The revolutionary cancer treatment? – PhysAssist Brands

FDA investigates CAR-T therapy as causing cancer in rare cases

Why There's a Severe Shortage of Cancer Drugs

Matty B Biotech

ICancer Event

U.S. FDA Approves Bristol Myers Squibb's Breyanzi® as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

False claim FDA said cancer treatments cause cancer

FDA approves exagamglogene autotemcel to treat beta-thalassemia